Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167452 · ClinicalTrials.gov registry record · Phase 4
Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT01167452 is a Phase 4 study that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 36 participants.
The verdict
NCT01167452, a Phase 4 study, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study will find how weight affects the dosing of a drug called sulfamethoxazole and trimethoprim. Currently, the amount of sulfamethoxazole and trimethoprim a patient receives is the same regardless of the patient's weight. The entire cohort was analyzed for the study outcomes. BMI groups were for recruitment purposes only and were not used for ordinal data analysis. All sulfamethoxazole and trimethoprim (Trade name is Bactrim or Septra) medication that you will receive in this study will be referred to as study medication within this informed consent form. This drug is a combination of two antibiotics, sulfamethoxazole and trimethoprim, which belongs to a class of medication known as "sulfones" and is approved by the US Food and Drug Administration (FDA) for the treatment of a wide variety of bacterial infections such as ear infections, urinary tract infections, bronchitis, traveler's diarrhea, and Pneumocystis carinii pneumonia. Sulfamethoxazole and trimethoprim is given orally.
Interventions
- DRUG Sulfamethoxazole/trimethoprim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01167452
The ClinicalTrials.gov registry entry for NCT01167452 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sulfamethoxazole/trimethoprim is the first listed.
NCT01167452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01167452 about?
NCT01167452 is a clinical study titled "Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations". This study will find how weight affects the dosing of a drug called sulfamethoxazole and trimethoprim. Currently, the amount of sulfamethoxazole and trimethoprim a patient receives is the same regardless of the patient's weight. The entire cohort was analyzed for the study outcomes. BMI groups were ...
What is the current status of trial NCT01167452?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2010-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01167452?
The interventions under investigation include: Sulfamethoxazole/trimethoprim (DRUG).
Who is sponsoring clinical trial NCT01167452?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.